SCHEMBL5907253

SCHEMBL5907253

CCCCc1ccc(-n2ncc(CN3CCOCC3)c2-c2ccccc2F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A13 Q16696 2/20 0.44
▸ MAPK14 Q16539 2/20 0.42
▸ PIK3CD O00329 3/20 0.39
▸ PIK3R2 O00459 3/20 0.39
▸ PIK3CA P42336 3/20 0.39
▸ PIK3CB P42338 3/20 0.39
▸ PIK3CG P48736 3/20 0.39
▸ PIK3R5 Q8WYR1 3/20 0.39
▸ PIK3R3 Q92569 3/20 0.39
▸ SSTR5 P35346 1/20 0.39
▸ SMO Q99835 2/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ DRD4 P21917 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ POLB P06746 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7261984 0.86 CYP2A13 (0.49) CYP2A13PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL5907238 0.85 CYP2A13 (0.50) CYP2A13PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL5731706 0.83 CYP2A13 (0.46) CYP2A13SSTR5SMODRD2DRD4
SCHEMBL5907421 0.83 CYP2A13 (0.46) CYP2A13PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL5907335 0.82 CYP2A13 (0.47) CYP2A13PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL5730763 0.81 KMT2A (0.46) CYP2A13SSTR5DRD2DRD4DRD3
SCHEMBL5907359 0.81 SMO (0.51) CYP2A13SMOALDH1A1LMNAKMT2A
SCHEMBL5907306 0.80 CYP2A13 (0.45) CYP2A13PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL5907325 0.80 CYP2A13 (0.45) CYP2A13PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL5730793 0.80 CYP2A13 (0.45) CYP2A13MAPK14PIK3CDPIK3R2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264419-A1 Substituted pyrazoles MERCK PATENT GMBH (DE) 2006-11-23 — — US disclosed
CN-1768051-A Substituted pyrazoles MERCK PATENT GMBH (DE) 2006-05-03 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264419-A1 Substituted pyrazoles HTR3A, HTR1A, HTR1D CYP2A13 659/4885MAPK14 3592/4885PIK3CD 4385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback